SynthesisDrug design, development and therapy2018

Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Xiaofei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.